{"id":113025,"date":"2026-08-08T08:45:10","date_gmt":"2026-08-08T08:45:10","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/113025\/"},"modified":"2026-08-08T08:45:10","modified_gmt":"2026-08-08T08:45:10","slug":"alps-edges-up-on-quarterly-figures","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/113025\/","title":{"rendered":"ALPS Edges up on Quarterly Figures"},"content":{"rendered":"<p>                                                &#13;<br \/>\n                                                    &#13;<\/p>\n<p>Alps Group Inc (NASDAQ: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced its financial results for the year ended March 31, 2026, and provides a business update. <br \/>Completed the Business Combination with Globalink in October 2025 and began trading on the NASDAQ Global Market under the ticker symbol \u201cALPS\u201d.<\/p>\n<p>&#8220;Fiscal year 2026 was a transformational year for Alps. We completed our Business Combination with Globalink Investment Inc. and began trading on the Nasdaq Global Market under the ticker symbol &#8216;ALPS,&#8217; giving us a stronger platform to execute against our long-term strategy,&#8221; said Dr. Tham Seng Kong, Managing Director and Group Chief Executive Officer of Alps Group Inc. &#8220;At the same time, we grew revenue 44% year-over-year, advanced our cellular therapy pipeline and sharpened our research and development focus on the areas where we see the greatest opportunity to deliver value for patients and shareholders.&#8221;<\/p>\n<p>ALPS shares gained 0.09 cents, or 2.1%, to 42 cents.<\/p>\n","protected":false},"excerpt":{"rendered":"&#13; &#13; Alps Group Inc (NASDAQ: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced its financial&hellip;\n","protected":false},"author":2,"featured_media":113026,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[16],"tags":[50],"class_list":["post-113025","post","type-post","status-publish","format-standard","has-post-thumbnail","category-alps","tag-alps"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117059015979533882","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/113025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=113025"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/113025\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/113026"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=113025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=113025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=113025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}